CLINICAL_TRIALS
trial_result
· 2017-03-16
Clinical Trial Update: A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases [Phase 3]
Summary
Phase 3 trial of NewGam, a human immunoglobulin 10%, in primary immunodeficiency diseases has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Octapharma | Conditions: Primary Immunodeficiency Diseases | Phase 3 | Status: COMPLETED | Results posted: 2017-03-16